:: Educational Qualification
  Graduation :   M.Sc Hons school Biochemistry from Panjab UniversityChandigarh in year 1980
  Post Graduation :   PhD Immunology from Panjab UiversityChandigarh in year 1987
  Other Qualification.(1)      :   Post Doc Fellowship from Univ Texas Hlth Sci Ctr San Antonio USA in year 1991
     
 :: Area of Interest
       Area Of Interest       :
Immunology of Infectious Diseases, HIV, HCV, Leishmaniasis
Cancer Stem cells
Mesenchymal Stem cells
     
 :: Research & Projects
      Extramural Projects       :
      Departmental / P.G.I.
      Projects      		 :

To delineate the molecular pathways associated with origin/expansion of Cancer Stem Cells in human breast carcinoma
      Research In
      Progress      		 :
1. To evaluate the parameters that may be responsible for intra-tumoral enrichment of cancer stem cells in the breast cancer
2. Evaluating The Safety And Efficacy Of Umbilical Cord Derived Mesenchymal Stem Cell (hUC-MSCs) Transplantation For Treatment Of Rheumatoid Arthritis.
3. T cell epitope based vaccine designing for visceral leishmaniasis: an experimental study
4. Elucidating the molecular mechanisms of DC dysfunction in non-responders to antiviral therapy in individuals infected with HCV Genotype 3
      Area Of
      Specialization      		 :
Mesenchymal Stem Cells
Cancer Stem cells
Immunology of Infectious Diseases
      Future Plans       :
To develop protocols for induced pleuripotent stem cells for use in degenrative diseases using biodegradable scaffolds
      Awards & Honours       :
Indo-US UNAID-DBT Young Investigator Award-1991
Membership of the National Academy of Medical Sciences (India)-2004
      Member Of Professional
      Bodies      		 :
Vice President (Research)- The Cytometry Society (India)
Life Member- Indian Immunology Society
Life Member-AIDS Society of India
Life Member- The Cytometry Society (India)
Life member- Indian Society of Parasitology
     
 :: Publications(In Vancouver Style)

1.        Modified enzymelinked immunosorbant assay with excreted factor of Leishmania mexicana. AroraSK and Sehgal S. Ind J Parasitol;1984; 6: 97-98.

2.        A sensitive ELISAfor detection of circulating antigen for sero-diagnosis of kala azar. Sinha R, Arora SK and Sehgal S. Ind J Med Res, 1988; 5:64-67

3.        Role ofimmunosuppression in Leishmania mexicana induced lesions in hamsters. Sehgal Sand Arora SK. Ind J Med Res,1985; 81:157-161.

4.        Use of excretedfactor of Leishmania mexicana in sero-diagnosis of kele azar. Arora SK,Datta U and Sehgal S. Ind J Med Res, 1985; 81: 157-161.

5.        Effect oftemperature on footpad lesions induced by Leishmania mexicana. Sehgal S andArora SK. Ind J Med Res,1987; 30: 25-29.

6.        diagnostic problemsof kala azar in non-endemic areas. Datta U, Sehgal S and Arora SK. Ind J Path Microbiol, 1987;30:25-29.

7.        Evaluation of CIEPfor sero-diagnosis of kala azar. Datta U, Arora SK, Sinha R and RayatCS. Bull PGI, 1988; 22:96-99.

8.        A sensitive ELISAfor detection of circulating antigen for sero-diagnosis of kala azar. Sinha R, AroraSK and Sehgal S. Ind J Med Res,1988; 5:64-67

9.        AIDS in India: adiffering spectrum. Sehgal S, Arora SK and Grewal GS. Virus Information Exchange Newsletter1988; 88:138-142.

10.      AIDSin India: a report of three cases with review of literature. Sehgal S, AroraSK, Rajwanshi A and Deodhar SD. AsiPac J Immunol 1989; 6:39-42.

11.      Identificationof major antigens of Leishmania donovani promastigotes using kala azar sera. AroraSK and Sehgal S. Med MicrobiolImmunol 1988; 178:81-88.

12.      Receptormediated drug-delivery of macrophages: a novel chemotherapeutic approachagainst leishmaniasis. Mukhopadhyaya A, Chaudhri G, Arora SK, Sehgal Sand Basu SK. Science 1989;244:705-707.

13.      Useof whole parasites for quick screening of hybridomas against leishmaniadonovani. Sinha R, Arora SK and Sehgal S. Hybrydoma 1989; 8:259-261.

14.      HIVinfection in students: a new problem in India. Sehgal S, Kumar B, Arora SKand Kumar S. Virus InformationExchange Newsletter 1989; 6:20-21.

15.      Genitalherpes- a marker of HIV infection. Kumar B, Rajagopalan M, Arora SK andSehgal S. Ind J Dermatol VenereolLeprol, 1990; 56:387-388.

16.      Detectionof HPV in carcinoma by DNA hybridisation. Arora SK, Sehgal S and GuptaBD. Virus Information ExchangeNewsletter 1991; 8:72.

17.      Incidenceof HPV-6 and HPV-11 in genital warts in Chandigarh. Arora SK, Jain A,Kumar B and Sehgal S. VirusInformation Exchange Newsletter 1991; 8:71-72.

18.      Incidenceof HPV-6 and HPV-11 in women with healthy cervix. Jain A, Arora SK,Malhotra S and Sehgal S. VirusInformation Exchange Newsletter 1991; 8:72-73.

19.      Useof in vitro method to assess different brands of anti-leishmania drugs. AroraSK, Sinha R and Sehgal S. MedMicrobiol Immunol 1991; 180:21-27.

20.      Detectionof leishmania antigen in kala azar patients using monoclonal antibodies. Sinha R, Arora SK, Datta U and Sehgal S. Med Microbiol 1992; 36:391-400.

21.      Humoralantibody response in leishmania tropica infection. Sehgal S, Sinha R, MallickR, Arora SK and Hazra PK. JInfect 1992; 24:311-316.

22.      Useof monoclonal antibodies for the detection of leishmania antigens in kala azarpatients. Sinha R, Sehgal S, Datta U and Arora SK. Microbiol Immunol 1992; 32:391-400.

23.      Comparativeevaluation of the anti-heat shock protein antibodies in SLE and healthycontrols. Arora SK, Singh G and Sehgal S. Scand J Rheumatol. 1995; 24:160-163.

24.      Lackof serological specificity of recombinant leishmania hsp70. Arora SK,Melby PC and Sehgal S. Immunol CellBiol 1995; 73:446-451.

25.      Recombinantheat shock protein is recognised from individuals with prior L.donovaniinfection. Arora SK, Sehgal S, Tryon VV and Melby PC. Immunol Infect Dis 1995;5:282-286.

26.      Recentadvances in the technology for diagnosis of tuberculosis. In, New Biology,etd RC Sobti, Pb Univ publications, Chandigarh, 1996; pp62-72.

27.      Geneticpolymorphism in leishmania isolates using restriction enzyme lengthpolymorphism of kDNA and cDNA probes. Kapoor GS, Arora SK and Sehgal S. Med Microbiol Immunol 1998;186:209-214.

28.      Heterogeneityin the heat shock protein gene of leishmania isolates. Arora SK,Singh G and Sehgal S. Immunol CellBiol 1998; 76:186-189.

29.      Effectof growth hormone on fibrinolytic system in rat. Bubber P, Singh KP, Arora SKand Bansal DD. Ind J Exp Biol1998; 36:514-516.

30.      Managementof presumed intraocular tuberculosis: possible role of polymerase chainreaction. Gupta V, Arora SK, Gupta A, Ram J, Bambery P and Sehgal S. Acta Ophthalmol Scand 1998;76:679-682.

31.      Molecularcharacterisation of leishmania isolates. Arora SK, Kapoor GK and Sehgal S. J Parasit Dis 1998; 22:71-78.

32.      Basicconcepts in genetics:molecular techniques to detect DNA, RNA and proteins. Arora SK.In Proc Int Sym Ind Soc HearingSpeech therapists, Chandigarh, Feb 1999.

33.      Diagnosticefficacy of polymerase chain reaction in granulomatous uveitis. Arora SK,Gupta V, Gupta A, Bambery P, Kapoor GS and Sehgal S. Tubercle Lung Dis 1999; 79:229-233.

34.      Developmentof polymerase chain reaction dot-blotting system for detecting cutaneoustuberculosis. Arora SK, Kumar B and Sehgal S. Br J Dermatol 2000; 142:72-76.

35.      Anti-hspantibodies in patients with SLE: a disease activity related profile. Arora SK,Wanchu A, Bambery P, Singh KJ and Datta U. AplarJ Rheumatol 2000; 3:3-7.

36.      Identificationof sero-specific epitope of recombinant hsp70 of leishmania donovani. Arora SK,Kaur D, Kapoor GS and Sehgal S. JParsit Dis 2000; 24:19-22.

37.      Diagnosisof congenital tuberculosis using polymerase chain reaction. Kaur A, Marwaha R, Arora SKet al. Am Ped Infect Dis J 2000; 19:1109-1111.

38.      Demonstrationof monoclonality in peripheral blood lymphocytes in Multiple Myeloma. Datta U, Rakesh KN, Varma S, Varma N and Arora SK.ProcInt Symp Recent Advances in Mol Biol Allergy Immunol,Baroda, India, Sept 2000.

39.      Polymerasechain reaction positive tubercular retinal vasculitis: Clinical characteristics& management. Gupta A, Gupta A, Arora SK, Bambery P and Sehgal S. Retina 2001; 21:435-444.

40.      Evaluationof polymerase chain reaction for the detection of Mycobacterium tuberculosis inpleural fluids. Babu NS, Sehgal S, Jindal SK and Arora SK. Chest 2001; 119:1737-1741.

41.      Declinein beta2 microglobulin levels after anti-tubercular therapy among HIV/TBinfected individuals. Wanchu A, Arora SK, Bhatnagar A, Sud A, BamberyPand Singh S. Ind J Chest Dis AlliedSci. 2001; 43:211-215.

42.      Suppressionof beta2 microglobulin by pentoxiphylin therapy in asymptomatic HIV infectedindivisuals. Wanchu A, Arora SK, Bhatnagar A, Sud A, Bambery P, Singh S. Ind J Med Res 2001; 113:75-77.

43.      Riskassessment in Gene therapy. Anand A and Arora SK. Chapter in ‘Manufacturing of gene therapeutics:Methods, Processing, Regulations and Validation’ Ed G Subramanian,Kluwer academic/Plenum publishers, New York 2002; pp331-337.

44.      Analysisof intracellular cytokines by flow cytometery. Arora SK. Proc of the Indo-US workshop on Advanced Flow CytometryUniv of Miami, USA 17-22nd Feb, 2002.

45.      Tuberculosis:New advancements in diagnosis. Arora SK and Babu N. Editorial in CHEST 2002, 3(4): 179-180

46.      HIVin North India: A profile of year 2000. Datta U, Arora SK, Minz RW, and James I.Submitted to the BULLETIN OF PGI2002, 36(4):138-143.

47.      Analysisof intracellular cytokines using flowcytometry. Arora SK. METH CELL SCI. 2002; 00:1-4.

48.      Prevalenceof HIV infection among high risk groups and STD clinic attendees in Chandigarh:A 7-year study. Sehgal S, Mujtaba S, Arora SK, Minz R and Kumar B. IND J SEX TRANSM DIS, 2002; 23:14-18.

49.      MonoclonalGene arrangement in peripheral blood lymphocytes in Multiple Myeloma Rakesh KN,, Datta U, Varma S, Varma N, and Arora SK. PGI BULLETIN 2003, 37: 48-51.

50.      Presumedtubercular serpiginous choroiditis: clinical presentations and management.Gupta V, Gupta A, Arora SK., Bambery P, Dogra MR, Agarwal A. OPHTHALMOL  2003;110: 1747-1752.

51.      Recognition of Leishmania donovani by CD4+ T-cellsof naïve healthy uninfected individual, Pal N and Arora SK. Submitted toJ PARASIT DIS, 2004; 28:11-16.

52.      Beta-2microglobulin as a surrogate marker for HIV infection: good correlation withCD4 counts. Wanchu A, Arora SK, Bhatnagar A, Sud A, Bambery P, Singh S. IND J PATHOL MICROBIOL 2004;47:298-301.

53.      SerumInterleukin-2 and interleukin-4 levels in patients with Sarcoidosis: influenceof corticosteroid therapy. Gupta D, Jain P, Balamughesh T, Arora SK andWanchu A. LUNG INDIA 2005; 22:12-15.

54.      Recombinantantigens of Leishmania donovani inducing IFN-g release from Leishmania specificcell line, Arora SK, Pal NS & S.Mujtaba. EXP PARASIT 2005; 109:163-170.

55.     Incidence ofLamivudine resistance associated mutations in pol-gene of HIV-1 in patients from North India: A preliminaryreport. Sachdeva N, Sehgel S,  Datta U and Arora SK*. IND JPATHOL MICROBIOL, 2005. ; 48: 337-340.

56.     Simultaneous choroidalgranuloma and epididymo-orchitis in tuberculosis: Short communication. Gupta V, Arora SK, Sachdeva, N., BamberyP and Gupta A. Paper accepted in AM J OPHTHAL 2005; 140:310-312.

57.     Bcl2 and ROS1 expression in human meningiomas: an analysis with respectto histological subtype, Girish V, Pal NS, Anand A, Minz RW, Radotra BD and AroraSK. IND J PATHOL MICROBIOL, 2005; 48: 325-330.

58.     Frequency of drug-resistance mutation coexisting with wild type intreatment-naïve patients in India. Sachdeva N, Sehgal S and Arora SK. eJINT AIDS SOC, Medscape General Medicine 2005: 7(3).

59.     Immune responses in patients with HIV inferction after vaccination withrecombinant Hepatitis B virus vaccine. N Pasricha, U Datta, Y Chawla, S Singh, Arora SK, A Sud, R W Minz, B Saikia, H Singh, I James, SSehgal. BMC Infectious Diseases, Nov, 2005.

60.     Poor response to Recombinant HBVvaccination in patients with HIV infection. Pasricha N, Datta U, Chawla YK,Singh S, AroraSK, Sud A, Minz RW, Saikia B, Singh H, James I and Sehgal S. TROPICAL GASTROENTEROLOGY 2005; 26(4):

61.     Study of apoptosis in skin lesions of leprosy in relation to treatmentand lepra reactions. Ajith, Gupta S, Arora SK, Kumar B. INT J LEPROSY 2005; 73(4):269-276.

62.     Functional study of CD4+CD25+ Regulatory T-Cells inhealth and autoimmune hepatitis. Longhi MS, Hussain MJ, Rigai RR, Arora SK, Vergani GM, Vergani D and Ma Y.                 J  IMMUNOLOGY2006, 176: 4484–4491.

63.     Comparative analysis of HBV and HCV infection in hepatocellularcarcinoma and chronic liver disease- an autopsy based study. Vaiphei K, Pal NSand AroraSK. IND J PATH MICROBIOL2006; 49(3): 357-361.

64.     Successful management ofTubercular Subretinal granuloma. Gupta V, Gupta A, , Sachdeva N, Arora SK,Bambery P. OCCUL IMMUNOL INFLAMM2006;14:35-40.

65.       Detection of high-risk humanpapilloma virus type 16/18 in cutaneous warts in immunocompetent patients,using polymerase chain reaction. Payal R, Gupta S, Aggarwal R, Handa S, RadotraBD and AroraSK. DERMATOL ONLINE JOURNAL2006 Oct 31;12(6):1.

66.      Fungal endophthalmitis complicatingsubconjunctival injection of triamcinolone acetonide in anterior scleritis.Singh R, Gupta V, Chakarborty A, Nijhawan R, Arora SK, Gupta A. ANN OPHTHALMOL (SKOKIE). 2006 Fall;38(3):253-6.

67.      Prevalenceof high risk Human Papillomavirus infection in women with benign cervicalcytology using Polymerase chain reaction: A hospital based study from NorthIndia. Aggarwal R., Gupta S, Kaur S, Arora SK. IND J CANCER,2006; 43(3):109-115.

68.     Environment and Immunity. Arora SK and GuptaS. A chapter contributed to ‘ENVIRONMENTAL HEALTH: HUMAN PERSPECTIVE’book edt by Rai DV;  Anamaya publishers,New Delhi. Sept 2006.

69.     Non-functioning mediastinalparathyroid adenoma with sarcoid-like granulomatous lymphadenopathy- casereport” Amanjit Bal, Sachdeva MS, Joshi KJ, Bahera A, Arora SK and GuptaS. APMIS 2007; 115:784-788.

70.      IntratumoralFOXP3 expression in infiltrating breast carcinoma: its association withclinicopathologic parameters and angiogenesis” Gupta S, Joshi K, Wig JD and AroraSK. ACTA ONCOLOGICA. 2007; 46(6):792-7.

71.      Expressionof Interferon-gamma inducible protein IP-10 and its receptor CXCR3 in chronicpancreatitis. Singh L, Wig JD, Vasishta RK and Arora SK. PANCREATOLOGY 2007; 7(5): 479-490.

72.      An epitope-specific PCR test for diagnosisLeishmania donovani infections. Arora SK, Gupta S, Sachdeva N. TRANS R SOC TROP MED HYG 2007;102(1):41-45.

73.     Characteristics of Leishmania spp. isolatedfrom a mixed focus of Cutaneous and visceral leishmaniasis in Himachal Pradesh.Sharma NL, Sood A, Arora SK, Kanga A, Mahajan VK,  NegiAK and Sharma AK. J MED SCI RES (inpress) 2008.

74.     Drug-resistance associated genotypic alterations in pol-gene of HIVisolates from ART-naïve individuals in North India. Arora SK, Gupta S,Toor JS, Singla A. AIDS RES HUM RETROVIRUSES 2008; 24(2):125-30.

75.      Mitochondrial dysfunction and apoptosis of acinar cells in chronicpancreatitis. Singh L, Bakshi DK. Majumdar S, Arora SK, Vasishta RK andWig JD. J GASTEROENTEROL. 2008; 43(6): 473-83.

76.     Primary culture of pancreatic (human)acinar cells. Singh L, Bakshi DK, Wig JD, Vasishta RK and AroraSK. DIGESTIVE DIS SCI, 2008;53(9):2569-75.

77.     Human Papillomavirus and Skin Tag- is thereany association? Gupta S, Aggarwal R, Gupta Somesh, Arora SK. IND J DERM VENEREOL LEPROL 2008; 74(3):222-225.

78.     Experimentally induced various inflammatorymodels and seizure: Understanding the role of cytokine in rat. Rao R S, MedhiB, Saikia U N, Arora SK, Jaideep S Toor, Pandhi P, Khanduja K L. EURO PSYCHOPHARMACOL2008 (in Press) (IF 3.799)

79.      Increased frequency ofintra-tumoral CD4+ CD25+ Treg cells in hepatocellular carcinoma. Thakur S,Singla A, Rajwanshi A, Chawla Y and Arora SK. Abstract in J HEPATOLOGY, Volume 48, Supplement 2(2008), S136.

80.      Hepatitis C virus co-infection in HIV infected patients: A North Indiancohort study. Singla A, Arora SK. In press article IND J GASTEROENT2008; 27 (5): 215.

81.      Cellular defects in HIV infection. Singla Aand Arora SK. PROC INT CONFBIOTECH APP NEUROIMMUNOMODULATION INFEC DIS, Nov 2008, pp 481-498.

82.      Vaccination with anovel recombinant Leishmania antigen along with MPL provides partialprotection against L. donovani challenge in experimental model ofvisceral leishmaniasis. Bhardwaj S, Vasishta RK and Arora SK. EXPPARASITOL 2009; 121:29–37.

83.     Characteristics of Leishmania spp. isolatedfrom a mixed focus of Cutaneous and visceral leishmaniasis in Himachal Pradesh(India). Sharma NL, Sood A, Arora SK,Kanga A, Mahajan VK,  Negi AK and Sharma AK. THE INTERNET JTHIRD WORLD MEDICINE, 2009; 7(2).

84.     High frequency of Loss of allelic integrityat Wilms’ tumor suppressor gene-1 locus in advanced breast tumors associatedwith aggressiveness of the tumor. Gupta, Sachin, Joshi, Kusum, Wig, J., Arora, SK. IND J CANCER 2009;46(4):301-308.

85.     Recent advances in Leishmania vaccinedevelopment. Bhardwaj S and Arora SK.PROC NATL ACAD SCI (INDIA). 2009 (Section B); 79(Spl Issue): 1-14

86.     Cervicogenital hCG and cervicallength for prediction of preterm delivery in asymptomatic women at high riskfor pre-term delivery. Adhikari K; Bagga R; Suri V; Masih S; Arora SK. ARCH GYN& OBSTET 2009; 280:565–572.

87.     Clinical profile of 516 children affected by HIV in a tertiary carecentre in northern India:14 years of experience. Singh S, Jata KR, Minz RW, AroraSK, Suri S, Sehgal S. TRANS ROY SOC TROP MED HYG. 2009, 103 (6),pp. 627-633.

88.     The Implications of Higher TGF-β1, IGF-II and IGF-1R mRNA Expression inInfiltrating Breast Carcinoma and Their Association with Tumorigenesis andAngiogenesis. Gupta S, Joshi K, Wig JD and Arora SK. AM J BIOMED SCI Mar2009; 1(2):157-165.

89.     Potential role ofCXCL10 in the induction of cell injury and mitochondrial dysfunction. Singh L, Arora SK, BakshiDK,Majumdar S, Wig JD. INT J EXPPATHOL 2009; Dec.22 (Epub ahead of print). PMID: 20041963.

90.     Dysfunction ofmonocyte derived dendritic cells in therapy naïve chronic hepatitis C patients.Rana D, Chawla YK, Arora SK. IND J GASTRO 2009;  28 (Suppl1):A90 [Abstract]

91.     Allopregnanolone, the active metabolite ofprogesterone protects against neuronal damage in picrotoxin-induced seizuremodel in mice. Singh S, Hota D,Prakash A, Khanduja KL, Arora SK,Chakrabarti A. PHARMACOL BIOCHEM BEHAVIOR 2010 Jan;94(3):416-22. Epub 2009 Oct17.

92.     Association of alpha 2A adrenergic receptorgene (ADRAlpha2A) polymorphism with irritable bowel syndrome, microscopic andulcerative colitis. Sikander A, Rana SV, Sharma SK, Sinha SK, Arora SK, Prasad KK, Singh K. CLIN CHIM ACTA. 2010; 411:59-63.

93.     To compare CSF adenosine deaminase levels and CSF-PCR for tuberculousmeningitis. Rana SV, Chako F, Lal V, Arora SK, Prabhakar S, Sharma SK,Singh K. CLIN NEUROL NEUROSURG. 2010; 112:424-30.

94.     Synthesis and Antileishmanial activity ofPiperoyl-Amino Acid Conjugates. Inder Pal Singh, Shreyans K Jain, AmandeepKaur, Sukhvinder Singh, Rajendra Kumar, Prabha Garg, Shyam S Sharma and Arora SK. EUR J MED CHEM.2010;45:3439-3445.

95.     Cervical length and cervicovaginal HCG for predictionof pre-term birth in women with signs and symptoms of pre-term labour. Bagga R,Takhtani M, Suri V, Adhikari K, Bhardwaj. S & Arora SK. J OBSTET GYNAE, 2010; 30(5): 451–455.

96.     Prospective monitoring of BK virus reactivation inrenal transplant recipients in north india. Thakur R, Arora SK, Nada R, Minz M,Joshi K. TRANSPLANT INFECT DIS. 2011; 13: 575-583.

97.     Expansion of peripheral and intratumoralregulatory T cells in hepatocellular carcinoma: Acase control study" Thakur S, Singla A, Chawla Y, Rajwanshi A, Kalra N,Arora SK. Submitted to IND J PATH MICROBIOL 2011; 54:448-53...

98.     Efficacy of Leishmaniadonovani ribosomal P1 gene as potential DNA vaccine inexperimental visceral leishmaniasis. Masih S, Arora SK  and Vasishta RK.EXP PARASITOL 2011; 129: 55-64.

99.     In Vitro Cytotoxicity of Multiwalledand Singlewalled Carbon Nanotubes on Human Cell Lines. Arora S, Kaur H, Kaur I,Kaur R, Bharadwaj S, Rana D, Arora SK, Bubber P, Bharadwaj L. J NANOTECH2011 (Accepted article in press).

100.   HBVspecific T-cell responses in hepatitis B. Rana D, Menachery J, Chawla YK,Duseja A, Dhiman RK, Arora SK. TROPGASTRO 2011; 32(4): 273-278.

101.   Monocyte-derived Dendritic cells in Non Alcoholic Fatty Liver Disease arematuration defective. Rana D, DusejaA, Chawla YK, Arora SK. J CLIN EXP HEPATOL, 2011; 1: A4 [Abstract]

102.   Formylatedphloroglucinols from Eucalyptus loxophleba foliage. Sidana, J, Singh S, Arora SK, Foley WJ, Singh IP.FITOTERAPIA 2011; 82: 1118–1122.

103.    Prediction of drug-resistance in HIV-1 Subtype C basedon protease sequences from ART naïve and first line therapy failures in NorthIndia using genotypic and docking analysis. Toor JS, Verma R, Gupta P, Garg P,Sharma A and Arora SK. ANTIVIRAL RESEARCH 2011;92:213-18.

104.    Establishment of reference CD4+ T cell valuesfor adult Indian population. Thakar MR, Abraham P, Arora SK, Balakrishnan P, Bandyopadhyay B, Joshi A, K. Devi R, RaviV, Vajpayee M, Desai A, Mohanakrishnan J, Narain K, Ray K, Patil S, Singh R, SinglaA and Paranjape R. AIDS RESEARCH AND THERAPY 2011 Oct 3;8(1):35.

105.     Terpenoidal constituents of Eucalyptusloxophleba ssp. Lissophloia Sidanaa J, Singh S, Arora SK, Foley WJ and Singh IP.PHARMACEUT BIOL. 2012; 50(7): 823–827.

106.    Downregulation of nuclear factor-κB signalling bypolyphenolic compounds prevents endotoxin-induced liver injury in a rat mode.Bharrhan, S; Chopra, K; Arora, SK;Toor, JD; Rishi, P. Accepted for publication INNATE IMMUNITY 2012;18(1):70-9.

107.    Increased frequency of NK cellsand plasmacytoid dendritic cells in HIV-exposed yet sero-negative individuals.Singla A, Jacobs R, Schmidt RE, Wanchu A and Arora SK. Afr J AIDS Res2012; 2:2-2..

108.     Dual Positivity of Donor and Recipient Plasmafor BK Virus Confers a High Risk for Development of BK Nephropathy in RenalAllograft. Thakur R, Joshi K, Minz M, Singla A, Nada R,  AroraSK, Jha V, and Sakhuja V. TRANSPLANTATIONPROCEEDINGS, 2012; 44:717–720.

109.    Paromomycin loaded albumin microspheres:Efficacy and stability studies. Khan W, Kumar R, Toor, JS, Arora SK, Neeraj Kumar DRUG TESTING AND ANALYSIS (wileyonlinelibrary.com) 2012,  DOI 10.1002/dta.389.

110.    Human Immunodeficiency Virus: Biology andNatural History Infection. Arora SK,Paranjape R, Tripathy S, Wanchu A. In: Somesh Gupta, Bhushan Kumar, eds. SEXUALLY TRANSMITTED INFECTIONS 2ndedn. New Delhi, India: Elsevier, 2012: Chapter66, pages 779-794. ISBN: 978-81-312-2809-8.

111.    Functional reconstitution ofdefective myeloid Dendritic Cells in chronic Hepatitis C infection onsuccessful anti-viral treatment. Rana D, Chawla Y, Duseja A, Dhiman RK, Arora SK. LIVER INTERNATIONAL2012; 32(7): 1128-37. Feb 6. doi: 10.1111/j.1478-3231.2011.02754.x. [Epub aheadof print].

112.    Maturation defective myeloid Dendritic Cells inNon-alcoholic fatty liver disease patients release inflammatory cytokines inresponse to endotoxin. Rana D, Chawla Y, Duseja A,Dhiman RK, Arora SK. HEPATOL INTNL2012 DOI 10.1007/s12072-012-9371-6.

113.    Defective maturation of dendritic cellsduring HIV-1 infection is associated with increased expression of SOCS-1. Sachdeva M, Sharma A, Arora SK. BMC INFECT DIS 2012, 12 (Suppl 1):P88. doi: 10.1186/1471-2334-12-S1-P88.

114.    CD20+ T cell numbers are decreased in untreated HIVpatients and recover after HAART. Förster F, Singla A, Arora SK, Schmidt RE, and Jacobs R. IMMUN LETT 2012.doi.org/doi:10.1016/j.imlet.2012.05.004.

115.    Immunohistochemicalcharacterization of North Indian population based study. Kuadawla S, Bal A,Joshi K, Arora SK and Singh G. APMIS © 2012 APMIS. DOI 10.1111/j.1600-0463.2012.02933.x.

116.    BRCA1-methylated sporadic breast cancers areBRCA-like in showing a basal phenotype and absence of ER expression. Bal A,Verma S, Joshi K, Singla A, Thakur R, AroraSK & Singh G. Virchows Arch. Eur J Path. 2013. DOI10.1007/s00428-012-1286-z.

117.    Prediction of NRTI drug resistance in HIV-1subtype C among first line antiretroviral-experienced virological failurepatients from North India using genotypic and docking analysis. Toor JS, KumarR, Garag P, Sharma A, Arora SK.J  AIDS CLIN RES 2013,doi:10.4172/2155-6113.S5-005.

118.    Hepatitis B Virus Reverse Transcriptase Mutations inTreatment-Naïve Chronic Hepatitis B Patients. Singla B, Chakraborti A, SharmaBK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK and Duseja A. J MED VIROL2013; 85:1155-62.

119.    Differential expression of Rac-1, CxCR4 andCCR5 on CD4 T-cells at different stages of HIV-1 disease relate to itsprogression in therapy-naïve individuals. Toor JS, Sharma A, Kamboj SS and Arora SK. J AIDS CLIN RES. 2013; 4:207.  doi:10.4172/2155-6113.1000207.

120.    Viral proteins mediate upregulation ofnegative regulatory factors causing downmodulated dendritic cell functions inchronic hepatitis C virus infection. Rana D, Chawla YK, Duseja A, Dhiman RK andArora SK. EUR MED J –HEPATOLOGY2013;1:68-76

121.    Hepatitis B Virus Reverse TranscriptaseMutations in Treatment Naı¨ve Chronic Hepatitis B Patients. Bhupesh Singla,Anuradha Chakraborti,  Bal KrishanSharma, Shweta Kapil, Yogesh K. Chawla, SunilK. Arora, Ashim Das, Radha K. Dhiman, and Ajay Duseja. J MED VIROL. 2013; 85:1155–1162.

122.    Success of Antiviral Therapy in ChronicHepatitis-C Infection Relates to Functional Status of myeloid Dendritic CellsRana D, Chawla YK  and Arora SK. Invited review submitted toSpecial issue, ‘Translational Research in Health and Disease’ in IND J MED RES.2013; 138(5): 766-778.

123.     Translocation and Toxicity of Docetaxel Multi-Walled Carbon NanotubeConjugates in Mammalian Breast Cancer Cells. Arora Shweta, Kumar R, Kaur H, RayatCS, Kaur I, Arora SK, Srivastava J,and Bharadwaj LM. J BIOMED NANOTECH 2014; 10:1-9.

124.     Highproducer haplotype (CAG) of -863C/A, -308G/A and -238G/A polymorphisms in thepromoter region of TNF-α gene associate with enhanced apoptosis oflymphocytes  in HIV-1 subtype C infectedindividuals from North India. Singh S, Sharma A, Arora SK. PLOS ONE.2014, 9(5): e98020. doi:10.1371/journal.pone.0098020.

125.     Mycobacteriumtuberculosis modulates the gene interactions to activate the HIV replicationand faster disease progression in a co-infected host. Toor JS, Singh S, SharmaA, Arora SK. PLOS ONE 2014; 9(9): e106815. Published: September 08, 2014. DOI:10.1371/journal.pone.0106815.

126.    Risk Factors for Transfusion TransmissibleInfections Elicited on Post Donation Counselling in Blood Donors: Need toStrengthen Pre-donation Counselling. Sachdev S, Mittal k, Patidar G, Marwaha N,Sharma RR, Duseja A, Chawla YK and AroraSK. Ind J Hematol Blood Transfus. Feb.2015. DOI 10.1007/s12288-014-0460-7.

127.    Perinatal Transmission of HIV in WomenReceiving Anti-retroviral Prophylaxis/Therapy during Pregnancy with Zidovudine,Lamivudine, Nevirapine: Experience at Tertiary Care Center in India. Meena K;Arora A; Bagga,R; Kalra A; Kumar P; Sharma A; Arora SK. Journal of Postgraduate Medicine, Education and Research,July-September 2015;49(3):00-00.

128.    Response to potent anti-HBV agents in chronichepatitis B and combined effect of HBV reverse transcriptase mutations. Singla B,Bhattacharyya R, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A.Gene 2015;

129.    Modified Release Biodegradable PolymericMicrospheres of Stavudine: Cell Viability, Cellular Uptake, Hemolysis Studiesand In Vivo Pharmacokinetics.Srivastava S; Kumar R; Arora SK and Sinha VR. Current HIV Research, 2015, 13, 000-000.

130.    Immunology of hepato­cellular carcinoma. Sachdeva M, Chawla YK, AroraSK. World J Hepatol 2015; 7(17): 2080-2090. dx.doi.org/10.4254/wjh.v7.i17.2080.

131.    Dendritic cells: The warriors upfront-turneddefunct in chronic hepatitis C infection. SachdevaM, Chawla YK, Arora SK. World JHepatol 2015, 7(19): 2202-2208. Doi: 10.4254/wjh.v7.i19.2202.

132.    Functional Impairment of Myeloid Dendritic Cellsduring Advanced Stage of HIV-1 Infection: Role of Factors Regulating CytokineSignaling. Sachdeva M, Sharma A and AroraSK.  Plos One 2015; 10(10: e0140852. DOI:10.1371/journal.pone.0140852.

133.     Combination of low producer AA-genotypes in IFN-c and IL-10 genes makesa high risk genetic variant for HIV disease progression. Singh S, Sharma A, andArora SK. Cytokine 2015; 77:135-44.

134.     Dominating expression of negative regulatory factors MHC Class-IIexpression on dendritic cells in chronic Hepatitis C infection. Tomer S, ChawlaYK, Duseja A, Arora SK. Wolrd JGastro 2016; 22(22): 5173-5182. Doi:10.378/wjg.v22.i22.5173.

135.     Leishmaniarecombinant antigen modulates macrophage effector function facilitating earlyclearance of intracellular parasites. Ratna A; Arora SK.Trans Roy Soc Trop Med Hyg 2016 110 (10):610-619. doi: 10.1093/trstmh/trw068.

136.     Differential sensitivity of HIV-1 isolates to inhibition bymannose-binding lectins reveals the heterogeneity of the virus envelopeglycosylation. Jan M, Arora SK. JAIDS Jan 2016. P-D12(DOI:10.1097/01.qai.0000479692.26227.99).

137.     Increased expression of negative regulators of cytokine signaling duringchronic HIV disease cause functionally exhausted state of Dendritic cells.Sachdeva M, Sharma A and Arora SK. Cytokine 91:118-123; 2017.

138.     68Ga-Pentixafor PET/CT demonstrating higher CXCR4 density in small celllung carcinoma than in non-small cell variant. Baljinder Singh, Ankit Watts,Rajender Basher, Harmandeep Singh, Amanjit Bal, Rakesh Kapoor, Sunil K. Arora,Hans J. Wester, B. R. Mittal, D. Behera. Eur J Nucl Med Mol Imaging, 2017;44:909-10. DOI 10.1007/s00259-017-3622-7.

139.     Manα1-2Man binding anti-HIV lectins enhance the exposure of V2i and V3crown neutralization epitopes on the V1V2 and V3 hypervariable loops of HIV-1Envelope. Jan M, Upadhyay C, Sharma A, Hioe CE, AroraSK. AIDS Research and Human Retroviruses- 2017 Mar21. doi: 10.1089/AID.2016.0262.

140.     N-glycan microheterogeneity of the HIV-1 envelope is involved in thedetermination of dendritic cell-specific ICAM-3 grabbing nonintegrin mediatedtrans-infection to T helper cells. Jan M, AroraSK. JAIDS (supplement); Mar.2017.

141.     Mo1421 Elevated Levels of IL-6 and IL-8 Predict Development ofRespiratory Failure in Patients With Acute Pancreatitis. Samanta J, Singh S,Prasad R, Arora SK, Kochhar RK. Gastroenterology150(4):S708 · April 2017

142.     Efficacyand Safety of Mycobacterium indicus pranii as an adjunct therapy in Category IIpulmonary tuberculosis in a randomized trial. Sharma SK, Katoch K, Sarin R,Raman. B, Jain N, Patel N, Ram J, Singla N, Saha PK, Sigh U, Chaudhary S,Banavalikar JN, Jain N, Sumanlatha G, Khamar BM, Dey B, Mitra DK, Arora SK, Bhaskar S, Gupta S and RaniR. Scientific Reports,  28 Apr, 2017. |7: 3354 | DOI:10.1038/s41598-017-03514-1.

143.      Innatesensing of HIV-1 by DC-SIGN on Dendritic Cells: degradation and presentationvs. transmission of virus to T cells is determined by glycan composition ofviral envelope. Jan M & Arora SK. AIDS Res Human Retrovir. 2017 Jul27. doi: 10.1089/aid.2016.0290. [Epub ahead of print].

144.     Heterogeneity in the glycan composition on the surface of HIV-1 envelopedetermines the sensitivity to lectins. Jan M, Upadhyay C, Sharma A, Hioe CE, Arora SK. PlosOne, 2018 Mar 26;13(3):e0194498. doi:10.1371/journal.pone.0194498. eCollection 2018

145.     Signature genes associated with Immunological Non-responsiveness toAnti-retroviral therapy in HIV-1 infection. Singh S, Toor JS, Sharma A andArora SK. AIDS 2016 (No. AIDS-D-16-00439, submitted 050516).